200,000+ products from a single source!

sales@angenechem.com

Home > Imidazoles > 143945-86-2

143945-86-2

143945-86-2 | 2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (Z)-

CAS No: 143945-86-2 Catalog No: AG007J9P MDL No:

Product Description

Catalog Number:
AG007J9P
Chemical Name:
2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (Z)-
CAS Number:
143945-86-2
Molecular Formula:
C13H12N2O2
Molecular Weight:
228.2466
IUPAC Name:
3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid
InChI:
InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)
InChI Key:
SHZKQBHERIJWAO-UHFFFAOYSA-N
SMILES:
OC(=O)/C=C\c1ccc(cc1)Cn1ccnc1

Properties

Complexity:
283  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
228.09g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
228.251g/mol
Monoisotopic Mass:
228.09g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
55.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
1  
XLogP3:
1.6  

Literature

Title Journal
Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials. Neurological research 20120501
Synthesis, crystal structure, and properties of a double-helical zinc(II) coordination polymer with Ozagrel drug. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120201
Sulfotanshinone sodium injection for unstable angina pectoris: a systematic review of randomized controlled trials. Evidence-based complementary and alternative medicine : eCAM 20120101
Fasudil and ozagrel in combination show neuroprotective effects on cerebral infarction after murine middle cerebral artery occlusion. The Journal of pharmacology and experimental therapeutics 20110701
Poly[{μ(3)-3-[4-(1H-imidazol-1-yl-methyl)phen-yl]prop-2-enoato-κN:η:κO}copper(I)]. Acta crystallographica. Section E, Structure reports online 20110501
[Effect of TXA2 inhibitor on the proliferation and apoptosis of hypoxic pulmonary artery smooth muscle cells of porcines]. Zhonghua yi xue za zhi 20110125
Thromboxane-prostanoid receptor expression and antagonism in dextran-sodium sulfate-induced colitis. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20110101
Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer. Molecular cancer 20110101
The inhibitory effect of non-steroidal anti-inflammatory drugs (NSAIDs) on the monophenolase and diphenolase activities of mushroom tyrosinase. International journal of molecular sciences 20110101
Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide. PloS one 20110101
Bihemispheric subcortical infarcts in the middle cerebral artery territory. Clinical medicine insights. Case reports 20110101
Ghrelin signaling in human mesenteric arteries. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100801
Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS. Intensive care medicine 20100501
Thromboxane A(2) promotes soluble CD40 ligand release from human platelets. Atherosclerosis 20100401
The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain, behavior, and immunity 20100301
A prostacyclin agonist with thromboxane inhibitory activity for airway allergic inflammation in mice. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20100201
[The study of relationship between platelet function and thrombus in patients with essential thrombocythaemia]. Zhonghua yi xue za zhi 20100126
Integrative meta-analysis of differential gene expression in acute myeloid leukemia. PloS one 20100101
Platelet function and spontaneous thrombolytic activity of patients with cerebral infarction assessed by the global thrombosis test. Pathophysiology of haemostasis and thrombosis 20100101
Polychlorinated biphenyls (PCBs) enhance metastatic properties of breast cancer cells by activating Rho-associated kinase (ROCK). PloS one 20100101
Hypersensitivity to thromboxane receptor mediated cerebral vasomotion and CBF oscillations during acute NO-deficiency in rats. PloS one 20100101
Effect of combination therapy with sodium ozagrel and panax ginseng on transient cerebral ischemia model in rats. Journal of biomedicine & biotechnology 20100101
A selective thromboxane A2 (TXA2) synthase inhibitor, ozagrel, attenuates lung injury and decreases monocyte chemoattractant protein-1 and interleukin-8 mRNA expression in oleic acid-induced lung injury in guinea pigs. Journal of pharmacological sciences 20091001
[Effects of sodium ozagrel in primary thrombocytosis combined with thrombosis]. Zhongguo shi yan xue ye xue za zhi 20091001
Thromboxane A(2) contributes to the mediation of flow-induced responses of skeletal muscle venules: role of cyclooxygenases 1 and 2. Journal of vascular research 20090801
Abnormalities of endothelium-dependent responses in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats are improved by chronic treatment with thromboxane A2 synthase inhibitor. Atherosclerosis 20090701
Retinal artery embolization during carotid angioplasty and carotid artery stenting: case report. Neurologia medico-chirurgica 20090501
In vitro effect of ozagrel on mushroom tyrosinase. The protein journal 20090501
Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial). Cerebrovascular diseases (Basel, Switzerland) 20090101
NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries. Vascular pharmacology 20090101
Chronic recanalization of dissection of the distal anterior cerebral artery: case report and review of the literature. Case reports in medicine 20090101
Ozagrel reverses streptozotocin-induced constriction of arterioles in rat retina. Microvascular research 20081101
[Diagnosis and management for acute ischemic stroke]. Rinsho shinkeigaku = Clinical neurology 20081101
Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis. Circulation research 20081024
Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats. Journal of gastroenterology and hepatology 20080701
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice. Microcirculation (New York, N.Y. : 1994) 20080701
Up-regulated thromboxane production in the rat liver with biliary obstruction does not contribute to promote hepatic injury. Shock (Augusta, Ga.) 20080601
Impairment of endothelium-dependent ACh-induced relaxation in aorta of diabetic db/db mice--possible dysfunction of receptor and/or receptor-G protein coupling. Naunyn-Schmiedeberg's archives of pharmacology 20080601
Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study. Neurologia medico-chirurgica 20080601
Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina. Experimental eye research 20080301
Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents. Oncogene 20080103
Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep. Critical care (London, England) 20080101
Effect of sodium ozagrel on the activity of rat CYP2D6. European journal of pharmacology 20071114
[Adverse effects of thromboxane receptor antagonists and synthase inhibitors]. Nihon rinsho. Japanese journal of clinical medicine 20071028
Involvement of inducible nitric oxide synthase in blood flow decrease in vein induced by hen-egg white lysozyme. Biological & pharmaceutical bulletin 20070701
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension (Dallas, Tex. : 1979) 20070301
Mediators of CD18/P-selectin-dependent constriction of venule-paired arterioles in hypercholesterolemia. Microvascular research 20070301
Ibuprofen or ozagrel increases NO release and l-nitro arginine induces TXA(2) release from cultured porcine basilar arterial endothelial cells. Vascular pharmacology 20070201
Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gerbils. Brain research 20070112
[Antiplatelet therapy for acute ischemic stroke]. Nihon rinsho. Japanese journal of clinical medicine 20061128
[Cerebral infarction]. Nihon rinsho. Japanese journal of clinical medicine 20061101
Effect of a selective thromboxane A2 synthetase inhibitor on the systemic changes induced by circulating pancreatic phospholipase A2. Journal of gastroenterology 20061101
[Sodium ozagrel]. Nihon rinsho. Japanese journal of clinical medicine 20061028
Potentiation by neuropeptide Y of 5HT2A receptor-mediated contraction in porcine coronary artery. European journal of pharmacology 20060821
Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations. The Journal of pharmacology and experimental therapeutics 20060501
Prostanoids as pharmacological targets in COPD and asthma. European journal of pharmacology 20060308
Edaravone diminishes free radicals from circulating neutrophils in patients with ischemic brain attack. Internal medicine (Tokyo, Japan) 20060101
Evidence for the involvement of the cyclooxygenase-metabolic pathway in diclofenac-induced inhibition of spontaneous contraction of rat portal vein smooth muscle cells. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20050801
Selective thromboxane A2 synthase inhibition by OKY-046 prevents cardiopulmonary dysfunction after ovine smoke inhalation injury. Anesthesiology 20050501
Prominent unilateral convergence palsy in a patient with a tiny dorsal midbrain infarction. European neurology 20050101
Role of leukotriene receptor antagonists in the treatment of exercise-induced bronchoconstriction: a review. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20050101
Higher viscosity participates in the regulation of coronary flow via nitric oxide and indomethacin-sensitive contracting factor. Canadian journal of physiology and pharmacology 20041201
[Clinical guidelines for stroke]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20041110
Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig. European journal of pharmacology 20040913
Involvement of thromboxane A2 (TXA2) in the early stages of oleic acid-induced lung injury and the preventive effect of ozagrel, a TXA2 synthase inhibitor, in guinea-pigs. The Journal of pharmacy and pharmacology 20040401
Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban. The Journal of pharmacology and experimental therapeutics 20040301
Different prostanoids are involved in bradykinin-induced endothelium-dependent and -independent vasoconstriction in rat mesenteric resistance arteries. Journal of pharmacological sciences 20040201
Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation. The journal of medical investigation : JMI 20040201
Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology (Baltimore, Md.) 20040101
Edaravone, a radical scavenger, may enhance or produce antiproliferative effects of fluvastatin, amlodipine, ozagrel, GF109203X and Y27632 on cultured basilar artery smooth muscle cells. Biological & pharmaceutical bulletin 20031201
Rhythmical contractions in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats. Pflugers Archiv : European journal of physiology 20031101
[The clinical effect of combination therapy with edaravone and sodium ozagrel for acute cerebral infarction]. No to shinkei = Brain and nerve 20030701
Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit. American journal of physiology. Heart and circulatory physiology 20030601
Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats. Life sciences 20030502
Dissecting aneurysm of the anterior cerebral artery with severe subarachnoid hemorrhage during treatment for cerebral infarction. Internal medicine (Tokyo, Japan) 20030501
Endothelium-derived prostaglandin H2 evokes the stretch-induced contraction of rabbit pulmonary artery. European journal of pharmacology 20030425
Effect of TTC-909 on cerebral infarction following permanent occlusion of the middle cerebral artery in stroke prone spontaneously hypertensive rats. Journal of pharmacological sciences 20030401
Role of intracellular Ca2+ in endothelium-dependent contraction and relaxation of rabbit intrapulmonary arteries. Life sciences 20030307
Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20030101
[A 50-year history of new drugs in Japan-the development and trends of hemostatics and antithrombotic drugs]. Yakushigaku zasshi 20030101
Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radical scavenger. Arzneimittel-Forschung 20030101
The effect of ozagrel sodium on photochemical thrombosis in rat: therapeutic window and combined therapy with heparin sodium. Life sciences 20021108
Intracoronary administration of a thromboxane A2 synthase inhibitor relieves acetylcholine-induced coronary spasm. Circulation journal : official journal of the Japanese Circulation Society 20020901
[A case of migrainous infarction accompanying idiopathic thrombocytopenic purpura]. Rinsho shinkeigaku = Clinical neurology 20020901
Effect of TTC-909 in a middle cerebral artery thrombosis model in stroke-prone spontaneously hypertensive rats. European journal of pharmacology 20020802
Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction. European journal of pharmacology 20020517
Semiquantitative dynamic computed tomography to predict response to anti-platelet therapy in acute cerebral infarction. Neuroradiology 20020401
Effect of ozagrel hydrochloride, a thromboxane synthetase inhibitor, on alcoholic beverage-induced bronchoconstriction in asthmatic patients. Prostaglandins, leukotrienes, and essential fatty acids 20020401
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Thrombosis and haemostasis 20020101
Thromboxane A2 inhibition: therapeutic potential in bronchial asthma. American journal of respiratory medicine : drugs, devices, and other interventions 20020101
[Strategy for circulatory disturbance]. Rinsho shinkeigaku = Clinical neurology 20011201
[Thromboxane A2 synthase inhibitor and receptor antagonist]. Nihon rinsho. Japanese journal of clinical medicine 20011001
Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life sciences 20010810
Thrombin inhibition attenuates neurodegeneration and cerebral edema formation following transient forebrain ischemia. Brain research 20010601
[Endothelin receptor antagonist, phosphodiesterase inhibitor, thromboxane inhibitor]. Nihon rinsho. Japanese journal of clinical medicine 20010601
The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats. Surgery 20010501
Effect of thromboxane A2 (TXA2) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs. Prostaglandins & other lipid mediators 20010501
A novel series of thromboxane A2 synthetase inhibitors with free radical scavenging and anti-peroxidative activities. Chemical & pharmaceutical bulletin 20010501
Roles of thromboxane A2 and leukotriene B4 in radicular pain induced by herniated nucleus pulposus. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20010501
Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding. European journal of pharmacology 20010413
L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats. Journal of hypertension 20010301

© 2019 Angene International Limited. All rights Reserved.